MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Mitochondrial and autophagy alteration in a new fatty acid hydroxylase-associated neurodegeneration (FAHN) model

    F. Mandik, S. Misera, Y. Kanana, B. Wilken, C. Klein, M. Vos (Luebeck, Germany)

    Objective: Establishing a FAHN Drosophila model to identify cellular disease mechanisms. Background: Fatty acid hydroxylase-associated neurodegeneration (FAHN) is an early-onset neurodegenerative disease that manifests brain…
  • 2022 International Congress

    To Prescribe or Not to Prescribe: Assessing the impact of Parkinson’s nurse prescribers

    A. Hand, K. Mcewan, A. Clarke, A. Bate, S. Dalkin, R. Bradford, C. Allen, K. Mcdonald, S. Mccarthy, K. Brittain (Newcastle upon Tyne, United Kingdom)

    Objective: Within the UK, after successful completion of a formally recognised programme Parkinson’s Nurse Specialists (PNS) can act as independent prescribers, and as part of…
  • 2022 International Congress

    Isolated craniocervical dystonia without neuropsychiatric manifestations associated with NMDA-receptor antibodies

    S. Waller, L. Williams, A. Lee, MW. Lin, H. Morales-Briceno, V. Fung (Westmead, Australia)

    Objective: N-methyl-D-aspartate receptor (NMDAR) encephalitis classically spans neuropsychiatric disturbance, autonomic dysfunction and salient movement disorders. Attenuated presentations are increasingly recognised; however, presentations with an isolated…
  • 2022 International Congress

    Pallidal firing rate and alpha oscillations correlate with the severity of clinical symptoms in patients with dystonia

    U. Semenova, R. Medvednik, A. Tomskiy, V. Popov, A. Sedov (Moscow, Russian Federation)

    Objective: To examined how pallidal activity correlates with symptom severity across dystonic patients. Background: The internal segment of globus pallidus (GPi) is the most common…
  • 2022 International Congress

    Clinical Manifestations of Autonomic Dysfunction in Parkinsonism Assessed by COMPASS-31 Questionnaire

    D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to describe the manifestations of autonomic disorders, including symptoms and related factors, in Parkinsonism cases ​​​​​​​ Background: Parkinsonism is a progressive neurodegenerative…
  • 2022 International Congress

    Autonomic dysfunction in p.A53T SNCA PD vs GBA PD and idiopathic PD : A study in a Greek population.

    AM. Simitsi, P. Kokotis, C. Koros, C. Bougea, N. Papagiannakis, R. Antonelou, I. Pachi, D. Papadimitrioy, M. Stamelou, L. Stefanis (ATHENS, Greece)

    Objective: Τo assess whether autonomic dysfunction occurs in p.A53T SNCA mutation carriers manifesting Parkinson’s Disease (A53T-PD), using both subjective and objective measures and to compare…
  • 2022 International Congress

    Altered Brain Connectivity in Hyperkinetic Movement Disorders: Systematic Review of Resting-State fMRI Studies

    R. Marapin, H. vd Horn, A. vd Stouwe, J. Dalenberg, B. de Jong, M. Tijssen (Groningen, Netherlands)

    Objective: Providing a comprehensive literature review of resting-state brain connectivity alterations using resting-state fMRI (rs-fMRI) in hyperkinetic movement disorders (HMD). We additionally discuss alterations from…
  • 2022 International Congress

    The reasons for referral to a Parkinson’s Clinical Psychology service

    R. Lewis-Morton, B. Mohamed, E. Thomas, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To understand the reasons for referral to a Parkinson's Clinical Psychology service. Background: In recent times, the psychological impact of Parkinson’s Disease has become…
  • 2022 International Congress

    Reported Clinical and Quality-of-Life Outcomes With 24-Hour Levodopa-Carbidopa Intestinal Gel Administration Compared With 16-Hour Administration

    N. Kovács, M. Simu, O. Sanchez Soliño, J. Parra, J. Alcazar, S. Snedecor, V. Fung (Pécs, Hungary)

    Objective: To evaluate any existing differences between the reported outcomes in patients with advanced Parkinson’s disease (APD) using continuous 16-hour (hr) infusions of levodopa-carbidopa intestinal…
  • 2022 International Congress

    Apomorphine Sublingual Film Versus Subcutaneous Apomorphine in the Treatment of OFF Episodes in Parkinson’s Disease: Results From an Assessment of Patient Satisfaction

    J. Schwarz, C. Carroll, G. Ebersbach, J. Kulisevsky, A. Tessitore, I. Zhang, A. Bowling, S. Wu, E. Pappert, A. Thach (Oberbayern, Germany)

    Objective: Evaluate treatment satisfaction with apomorphine sublingual film (SL-APO) vs subcutaneous apomorphine (SC-APO) for the treatment of OFF episodes in patients with Parkinson’s disease (PD).…
  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley